Chair and CEO Sharon Mates sold $7.1M of Intra-Cellular Therapies, Inc.

Sold$7,054,085

$73.54Price

95,925Shares

−8%Stake

What ITCI did after the filing

Prices for ITCI after this filing aren't in yet.

Traded Mon, Aug 26. Filed Wed, Aug 28, 6:00 PM ET, after the close. Not investment advice.